NGT i-IFG i-IGT IFG/IGT NDD Known diabetes
Men (n=1,429) (n=969) (n=75) (n=147) (n=42) (n=61) (n=135)
Hemoglobin OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
a Model 1 1.00 1.09 (0.81-1.46) 1.39 (1.11-1.74) 1.54 (1.04-2.27) 1.37 (0.99-1.89) 0.80 (0.64-0.99)
b Model 2 1.00 0.96 (0.70-1.31) 1.23 (0.97-1.57) 1.31 (0.86-1.97) 1.17 (0.83-1.64) 0.78 (0.62-0.98)
Hematocrit            
a Model 1 1.00 1.06 (0.80-1.42) 1.30 (1.05-1.62) 1.35 (0.92-1.96) 1.35 (0.98-1.85) 0.77 (0.62-0.96)
b Model 2 1.00 0.95 (0.69-1.29) 1.16 (0.92-1.47) 1.16 (0.77-1.73) 1.18 (0.84-1.64) 0.75 (0.59-0.94)
Platelet count            
a Model 1 1.00 1.06 (0.84-1.33) 1.02 (0.86-1.22) 0.76 (0.53-1.08) 0.91 (0.70-1.20) 0.76 (0.62-0.95)
b Model 2 1.00 1.10 (0.87-1.39) 1.04 (0.86-1.25) 0.79 (0.55-1.14) 0.97 (0.74-1.28) 0.79 (0.64-0.98)
Mean platelet volume            
a Model 1 1.00 1.09 (0.86-1.38) 0.98 (0.82-1.18) 1.27 (0.95-1.71) 1.00 (0.76-1.30) 1.27 (1.05-1.53)
b Model 2 1.00 1.05 (0.83-1.35) 0.95 (0.78-1.15) 1.18 (0.86-1.60) 0.90 (0.68-1.19) 1.19 (0.97-1.45)
White blood cell count            
a Model 1 1.00 1.03 (0.78-1.35) 1.37 (1.16-1.61) 1.18 (0.85-1.63) 1.41 (1.16-1.71) 1.34 (1.13-1.59)
b Model 2 1.00 1.01 (0.74-1.36) 1.32 (1.11-1.58) 1.11 (0.77-1.59) 1.33 (1.07-1.66) 1.18 (0.98-1.43)
Women (n=1,534) (n=1,161) (n=38) (n=168) (n=27) (n=47) (n=93)
Hemoglobin   OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
a Model 1 1.00 1.33 (0.86-2.07) 1.64 (1.30-2.07) 2.72 (1.61-4.62) 1.66 (1.11-2.47) 1.19 (0.89-1.58)
bModel 2 1.00 1.16 (0.73-1.82) 1.60 (1.25-2.06) 2.44 (1.41-4.23) 1.50 (0.98-2.29) 1.18 (0.86-1.62)
Hematocrit            
a Model 1 1.00 1.26 (0.83-1.93) 1.60 (1.28-2.00) 2.41 (1.44-4.01) 1.63 (1.11-2.41) 1.20 (0.90-1.59)
b Model 2 1.00 1.11 (0.71-1.72) 1.57 (1.23-2.00) 2.20 (1.29-3.76) 1.56 (1.02-2.38) 1.21 (0.88-1.66)
Platelet count            
a Model 1 1.00 1.19 (0.87-1.63) 0.96 (0.80-1.14) 0.81 (0.53-1.25) 1.12 (0.84-1.50) 0.96 (0.76-1.21)
b Model 2 1.00 1.16 (0.84-1.60) 0.95 (0.79-1.14) 0.81 (0.52-1.27) 1.13 (0.83-1.53) 1.01 (0.78-1.29)
Mean platelet volume            
a Model 1 1.00 1.12 (0.82-1.54) 1.10 (0.93-1.29) 1.19 (0.82-1.72) 1.10 (0.82-1.47) 1.26 (1.02-1.55)
b Model 2 1.00 1.11 (0.81-1.52) 1.09 (0.92-1.29) 1.16 (0.79-1.70) 1.06 (0.79-1.44) 1.18 (0.94-1.48)
White blood cell count            
a Model 1 1.00 1.37 (0.95-1.98) 1.51 (1.25-1.82) 1.70 (1.13-2.55) 2.19 (1.68-2.84) 2.07 (1.67-2.57)
b Model 2 1.00 1.16 (0.76-1.76) 1.56 (1.27-1.91) 1.54 (0.98-2.41) 1.87 (1.39-2.52) 1.84 (1.43-2.38)
NGT: Normal Glucose Tolerance; i-IFG: Isolated Impaired Fasting Glucose; i-IGT: Isolated Impaired Glucose Tolerance; NDD: Newly Detected Diabetes; Odds ratio (OR) expressed per SD-increment; significant findings are highlighted in bold characters; aModel 1: adjusted for age ; bModel 2: adjusted for age, actual hypertension, regular smoking, physical activity, alcohol intake, total cholesterol, HDL cholesterol, creatinine, and BMI
Table 3: Gender-specific association of hematological parameters with i-IFG, i-IGT, IFG/IGT, NDD, and known diabetes (comparisons with NGT), KORA F4 study.